Filter
159
Filtered Results: 159
Text search:
R.
Jenkins
Featured
Recommendations
14
New Publications
16
Language
Document type
No document type
98
Studies & Reports
30
Guidelines
23
Manuals
2
Training Material
2
Strategic & Response Plan
2
Fact sheets
2
Countries / Regions
Global
7
Russia
5
Western and Central Europe
4
Eastern Europe
4
Brazil
4
India
4
Kenya
3
Zimbabwe
3
Syria
2
Nigeria
2
Africa
2
Tanzania
2
South Africa
2
Uganda
2
Yemen
2
Ethiopia
2
Ukraine
1
Ghana
1
Rwanda
1
Chile
1
Malawi
1
Mozambique
1
Cambodia
1
Venezuela
1
Latin America and the Carribbean
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
South–East Asia Region
1
Namibia
1
Egypt
1
Palestine
1
Central African Republic
1
Zambia
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
34
Public Health
13
Clinical Guidelines
13
Key Resources
3
Women & Child Health
2
Toolboxes
Mental Health
38
COVID-19
18
TB
15
HIV
10
Disability
9
NCDs
9
Planetary Health
7
Caregiver
5
Social Ethics
4
Global Health Education
4
Refugee
3
Specific Hazards
2
Ebola
2
Pharmacy
2
AMR
2
NTDs
1
Health Financing Toolbox
1
Polio
1
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
Mental disorders are a leading cause of the global burden of disease, and the provision of mental health services in developing countries remains very limited and far from equitable. Using the Creditor Reporting System, we estimate the amounts and patterns of development assistance for global mental...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
Several challenges face asthma management in Egypt, including the high percentage of uncontrolled patients, inadequate compliance, and overuse of short-acting beta-agonists (SABAs) leading to increased asthma-related morbidity and mortality. In this regard, the recent Global Initiative for Asthma (G...
This integrated operational framework provides an overview of the connections between mental health, neurological and substance use (MNS) conditions, and their links to health, well-being and the broader public health and sustainable development agenda. The need for integrated approaches is increasi...
Prepared as an outcome of ICMR Subcommittee on Soft Tissue Sarcoma and Osteosarcoma | This consensus document on Management of Soft Tissue Sarcoma and Osteosarcoma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular ...
Severe cases of COVID-19 are associated with rehabilitation needs related to the consequences of ventilatory support, and prolonged immobilization and bed rest. These may include: − Impaired lung function; − Physical deconditioning and muscle weakness; − Delirium and other cognitive impairment...
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа...
Update, 23 de junio de 2022
Epidemiologisches Bulletin ; 12. Dezember 2016 / Nr. 49 aktuelle daten und informationen zu infektionskrankheiten und public health
THE RESEARCH FOUNDATION OF CEREBRAL PALSY ALLIANCE newsletter – NOVEMBER 2012
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
